Glenmark is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India
The anti-diabetic biosimilar has been launched under the brand name Lirafit™, and is indicated for improving glycemic control in adult patients…
Dr. T S Kler Padma Bhushan Awardee
MD, DM, MRCP, FRCP(U.K), FACC, D.Sc
Chairman – Fortis Heart Institute Gurugram
Precautions to avoid Corona Virus: